BDBM755283 2,2'',2″-(10-(2-((2-(3-((3-((3-((11R,14S,Z)-6-amino-11-((2,6-difluoro-4-hydroxybenzyl)carbamoyl)-14-(isoindolin-2-yl)-4,13-dioxo-3,5,7,12-tetraazatetradec-5-en-14-yl)phenyl)amino)propyl)amino)-3-oxopropoxy)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid ::US20250213735, Compound 14

SMILES CCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)[C@H](c1cccc(NCCCNC(=O)CCOCCNC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)c1)N1Cc2ccccc2C1)C(=O)NCc1c(F)cc(O)cc1F

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 755283   

TargetNeuropeptide Y receptor type 1(Human)
Radionetics Oncology

US Patent
LigandPNGBDBM755283(2,2',2″-(10-(2-((2-(3-((3-((3-((11R,14S,Z)-6-amino...)
Affinity DataKi: <10nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/23/2025
Entry Details
US Patent